The effects of enrofloxacin on decorin and glycosaminoglycans in avian tendon cell cultures.
Tendonitis and tendon rupture have been reported to occur during or following therapy with fluoroquinolone antibiotics. Though the pathogenesis is unknown, several studies suggest that fluoroquinolone antibiotics alter proteoglycan content in soft tissues, including tendons, and thereby alter collagen fibrillogenesis. To better understand the mechanism of action of fluoroquinolones, we studied the effects of enrofloxacin, a widely used fluoroquinolone in veterinary medicine, on avian tendon cell cultures established from gastrocnemius tendons from 18-day-old chicken embryos. We found that cell proliferation was progressively inhibited with increasing concentrations of enrofloxacin. This was accompanied by changes in morphology, extracellular matrix content and collagen fibril formation as detected by electron microscopy. We also observed a 35% decrease in the content of total monosaccharides in enrofloxacin-treated cells. The ratio of individual monosaccharides was also altered in enrofloxacin-treated cells. Enrofloxacin also induced the synthesis of small amounts of keratan sulfate in tendon cells. Moreover we observed enrofloxacin-induced changes in glycosylation of decorin, the most abundant tendon proteoglycan, resulting in the emergence of multiple lower molecular bands that were identifiable as decorin after chondroitinase ABC and N-glycanase treatment of extracts from enrofloxacin-treated cells. Medium conditioned by enrofloxacin-treated cells contained less decorin than did medium conditioned by control cells. We hypothesize that enrofloxacin induces either changes in the number of N-linked oligosaccharides attached to the core protein of decorin or changes in decorin degradation process. In conclusion, our data suggest that enrofloxacin affects cell proliferation and extracellular matrix through changes in glycosylation.
Yoon
Jung Hae
JH
Department of Pathology, College of Veterinary Medicine, The University of Georgia, Athens, GA 30602, USA.
Brooks
Randolph L
RL
Zhao
Jian Zeng
JZ
Isaacs
David
D
Halper
Jaroslava
J
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D002642:Chick Embryo; D017077:Culture Media, Conditioned / Q000737:chemistry / Q000378:metabolism; D058575:Decorin; D004305:Dose-Response Relationship, Drug; D000077422:Enrofloxacin; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism; D016326:Extracellular Matrix Proteins; D024841:Fluoroquinolones / Q000633:toxicity*; D008401:Gas Chromatography-Mass Spectrometry; D006025:Glycosaminoglycans / Q000378:metabolism*; D007632:Keratan Sulfate / Q000096:biosynthesis; D018482:Muscle, Skeletal; D011509:Proteoglycans / Q000032:analysis / Q000378:metabolism*; D015363:Quinolones / Q000633:toxicity*; D012155:Reticulin / Q000187:drug effects / Q000648:ultrastructure; D013710:Tendons / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure
D000970:Antineoplastic Agents; D017077:Culture Media, Conditioned; D058575:Decorin; D016326:Extracellular Matrix Proteins; D024841:Fluoroquinolones; D006025:Glycosaminoglycans; D011509:Proteoglycans; D015363:Quinolones; D012155:Reticulin; D000077422:Enrofloxacin; D007632:Keratan Sulfate